159 related articles for article (PubMed ID: 15686942)
1. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
Zhao H; Xin Z; Patel JR; Nelson LT; Liu B; Szczepankiewicz BG; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2005 Apr; 15(7):1825-8. PubMed ID: 15780615
[TBL] [Abstract][Full Text] [Related]
3. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
[TBL] [Abstract][Full Text] [Related]
4. Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.
Zhao H; Xin Z; Liu G; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
J Med Chem; 2004 Dec; 47(27):6655-7. PubMed ID: 15615511
[TBL] [Abstract][Full Text] [Related]
5. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
[TBL] [Abstract][Full Text] [Related]
6. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
[TBL] [Abstract][Full Text] [Related]
7. Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.
Liu B; Liu M; Xin Z; Zhao H; Serby MD; Kosogof C; Nelson LT; Szczepankiewicz BG; Kaszubska W; Schaefer VG; Falls HD; Lin CW; Collins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2006 Apr; 16(7):1864-8. PubMed ID: 16442284
[TBL] [Abstract][Full Text] [Related]
8. Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor.
Witherington J; Abberley L; Bellenie BR; Boatman R; Collis K; Dean DK; Gaiba A; King NP; Shuker N; Steadman JG; Takle AK; Sanger G; Butler S; McKay F; Muir A; Winborn K; Ward RW; Heightman TD
Bioorg Med Chem Lett; 2009 Feb; 19(3):684-7. PubMed ID: 19128969
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
Demange L; Boeglin D; Moulin A; Mousseaux D; Ryan J; Bergé G; Gagne D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
J Med Chem; 2007 Apr; 50(8):1939-57. PubMed ID: 17375904
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
[TBL] [Abstract][Full Text] [Related]
11. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
Kobayashi T; Sasaki S; Tomita N; Fukui S; Kuroda N; Nakayama M; Kiba A; Takatsu Y; Ohtaki T; Itoh F; Baba A
Bioorg Med Chem; 2010 Jun; 18(11):3841-59. PubMed ID: 20457527
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
Palin R; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Maclean J; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; McArthur D; McGregor D; McLuskey H; Neagu I; Neale S; Nisbet LA; Ohlmeyer M; Pham Q; Ratcliffe P; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Feb; 21(3):892-8. PubMed ID: 21236666
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of the oxindole growth hormone secretagogues.
Tokunaga T; Hume WE; Nagamine J; Kawamura T; Taiji M; Nagata R
Bioorg Med Chem Lett; 2005 Apr; 15(7):1789-92. PubMed ID: 15780607
[TBL] [Abstract][Full Text] [Related]
16. Proline bis-amides as potent dual orexin receptor antagonists.
Bergman JM; Roecker AJ; Mercer SP; Bednar RA; Reiss DR; Ransom RW; Meacham Harrell C; Pettibone DJ; Lemaire W; Murphy KL; Li C; Prueksaritanont T; Winrow CJ; Renger JJ; Koblan KS; Hartman GD; Coleman PJ
Bioorg Med Chem Lett; 2008 Feb; 18(4):1425-30. PubMed ID: 18207395
[TBL] [Abstract][Full Text] [Related]
17. Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
Bonnefous C; Vernier JM; Hutchinson JH; Chung J; Reyes-Manalo G; Kamenecka T
Bioorg Med Chem Lett; 2005 Feb; 15(4):1197-200. PubMed ID: 15686941
[TBL] [Abstract][Full Text] [Related]
18. Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
Ralbovsky JL; Lisko JG; Palmer JM; Mabus J; Chevalier KM; Schulz MJ; Dyatkin AB; Miskowski TA; Coats SJ; Hornby P; He W
Bioorg Med Chem Lett; 2009 May; 19(10):2661-3. PubMed ID: 19375913
[TBL] [Abstract][Full Text] [Related]
19. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC
Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.
Ratcliffe P; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; Maclean J; McArthur D; McGregor D; McLuskey H; Neagu I; Nimz O; Nisbet LA; Ohlmeyer M; Palin R; Pham Q; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4652-7. PubMed ID: 21723725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
